Immedica Pharma Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 200

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 4

  • Investments
  • 5

Immedica Pharma General Information

Description

Distributor of specialty pharmaceuticals intended to help in metabolic diseases, oncology, and ophthalmology. The company offers marketing, regulatory affairs, market access, and distribution services, enabling healthcare providers to access medicines for genetic, metabolic, hematology, and oncology conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Solnavagen 3H
  • 113 63 Stockholm
  • Sweden
+46 08-533
Primary Industry
Pharmaceuticals
Other Industries
Distributors (Healthcare)
Corporate Office
  • Solnavagen 3H
  • 113 63 Stockholm
  • Sweden
+46 08-533

Immedica Pharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immedica Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Immedica Pharma‘s full profile, request access.

Request a free trial

Immedica Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Distributor of specialty pharmaceuticals intended to help in metabolic diseases, oncology, and ophthalmology. The compan
Pharmaceuticals
Stockholm, Sweden
200 As of 2026

Stockholm, Sweden
 

Stockholm, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Immedica Pharma Competitors (2)

One of Immedica Pharma’s 2 competitors is Bluefish Pharmaceuticals, a Private Equity-Backed company based in Stockholm, Sweden.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bluefish Pharmaceuticals Private Equity-Backed Stockholm, Sweden
Chiesi Nordic Corporation Stockholm, Sweden
You’re viewing 2 of 2 competitors. Get the full list »

Immedica Pharma Patents

Immedica Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023254828-A1 Treatment of arginase 1 deficiency Pending 11-Apr-2022
EP-4508207-A1 Treatment of arginase 1 deficiency Pending 11-Apr-2022
EP-4508207-A4 Treatment of arginase 1 deficiency Pending 11-Apr-2022
JP-2025513844-A Treatment of arginase 1 deficiency Pending 11-Apr-2022
US-20250228921-A1 Treatment of arginase 1 deficiency Pending 11-Apr-2022 A61K38/50
To view Immedica Pharma’s complete patent history, request access »

Immedica Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Immedica Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Immedica Pharma‘s full profile, request access.

Request a free trial

Immedica Pharma Investments (5)

Immedica Pharma’s most recent deal was a Buyout/LBO with Neurocrine UK for . The deal was made on 21-Jan-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Neurocrine UK 21-Jan-2026 Buyout/LBO Drug Delivery
Marinus Pharmaceuticals 07-Feb-2025 Buyout/LBO Drug Discovery
Aeglea BioTherapeutics (Pegzilarginase Assets) 27-Jul-2023 Buyout/LBO Buildings and Property
Novartis (Rights for Ophthalmology Products) 01-Oct-2019 Buyout/LBO Other Pharmaceuticals and Biotechnology
Medical Need 27-Jul-2018 Buyout/LBO Pharmaceuticals
To view Immedica Pharma’s complete investments history, request access »

Immedica Pharma Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Immedica Pharma Germany Dusseldorf, Germany 2019
Medical Need Stockholm, Sweden 2011
Neurocrine UK Cardiff, United Kingdom 2004

Immedica Pharma FAQs

  • When was Immedica Pharma founded?

    Immedica Pharma was founded in 2018.

  • Where is Immedica Pharma headquartered?

    Immedica Pharma is headquartered in Stockholm, Sweden.

  • What is the size of Immedica Pharma?

    Immedica Pharma has 200 total employees.

  • What industry is Immedica Pharma in?

    Immedica Pharma’s primary industry is Pharmaceuticals.

  • Is Immedica Pharma a private or public company?

    Immedica Pharma is a Private company.

  • What is Immedica Pharma’s current revenue?

    The current revenue for Immedica Pharma is .

  • How much funding has Immedica Pharma raised over time?

    Immedica Pharma has raised $216M.

  • Who are Immedica Pharma’s investors?

    Kohlberg Kravis Roberts, Impilo, and Belnord Capital have invested in Immedica Pharma.

  • Who are Immedica Pharma’s competitors?

    Bluefish Pharmaceuticals and Chiesi Nordic are competitors of Immedica Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process